Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;143(1):110-6.
doi: 10.1111/j.1365-2249.2005.02955.x.

Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis

Zhao Xiaoyan  1 , R Pirskanen, V Malmstrom, A K Lefvert
Affiliations

Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis

Zhao Xiaoyan et al. Clin Exp Immunol. 2006 Jan.

Abstract

Myasthenia gravis (MG) is commonly regarded as the prototype of an antibody-mediated, organ-specific autoimmune disease. Antibodies against the acetylcholine receptor (AChR) on the muscle endplate trigger its typical clinical manifestations of weakness and fatiguability. T-B cell interactions are thought to play a crucial role in the pathogenesis of MG. OX40 (CD134), a costimulatory molecule that is expressed on activated CD4+ T-cells, might contribute to the development or pathogenesis of immune-mediated diseases such as rheumatoid arthritis and graft-versus-host disease. In the present study, we investigated the expression of OX40 on CD4+ T-cells from patients with MG and healthy individuals. Results from 36 MG patients and 28 healthy controls revealed that more freshly isolated CD4+ T-cells from MG patients expressed OX40 than cells from healthy individuals. High levels of antibodies against the AChR, thymic hyperplasia and onset at an early age were associated with elevated expression of OX40. Upon activation by various concentrations of anti-CD3 antibodies, CD4+ T-cells from MG patients showed a tendency toward higher levels of OX40 expression than cells from healthy individuals. Given the role of OX40 in the immune system, we conclude that OX40 might contribute to the development of MG.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
OX40+ expression on freshly isolated CD4+ T-cells from MG patients (n = 36) and healthy controls (HC) (n = 28) (P = 0·012). The vertical lines indicates the median levels of CD4+ T-cells expressing OX40.
Fig. 2
Fig. 2
Representative examples of flow cytometry plots showing (a) CD4+OX40+ T-cells from one MG patient (15·5% of total CD4+T-cells expressed OX40) and surface expression of (b) CD28 (100%) (c) CD152 (CTLA-4) (< 1%) (d) CD25 on CD4+OX40+ T-cells. CD4+OX40+ T-cells exhibited elevated CD25 (91%) expression compared with CD4+OX40- T-cells (54·5%).
Fig. 3
Fig. 3
(a) Induction of OX40 expression on CD4+ T-cells after 24 h (a). PBMC from MG (•, n = 5) and HC (▪, n = 5) were stimulated in parallel with immobilized anti-CD3 antibody at the indicated coating concentrations for 24 hRepresentative examples of flow cytometry plots showing (b) CD4+OX40+ T-cells from one MG patient stimulated with anti-CD3 antibody for 24 h and surface expression of (c) CD69 (89%) (d) CD152 (CTLA-4) (18%) on CD4+OX40+ T-cells.
See this image and copyright information in PMC

References

    1. Lennon VA, Lindstrom JM, Seybold ME. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann NY Acad Sci. 1976;274:283–99. - PubMed
    1. Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 1986;36:618–21. - PubMed
    1. Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang D, Pirskanen R, Lefvert AK. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol. 2002;130:224–32. - PubMed
    1. McIntosh KR, Linsley PS, Bacha PA, Bacha PA, Drachman DB. Immunotherapy of experimental autoimmune myasthenia gravis. selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein. J Neuroimmunol. 1998;87:136–46. - PubMed
    1. Croft M. Costimulation of T cells by OX40, 4–1BB, and CD27. Cytokine Growth Factor Rev. 2003;14:265–73. - PubMed

Publication types

Substances